Endpoints News 26. Feb. 2026 Novartis to build another radioligand factory; Germany steps up probe into Gerresheimer
Endpoints News 20. Feb. 2026 Novartis to divest India unit to private equity-led consortium for $159M
FierceBiotech 18. Feb. 2026 Novartis finds natural partner in macrocycle biotech, inking $1.7B-plus cardio deal
Endpoints News 18. Feb. 2026 Novartis signs macrocyclic deal with Unnatural Products for $100M upfront
Endpoints News 18. Feb. 2026 Lilly's Zepbound, Taltz combo data in psoriasis and weight loss; Novartis bolsters Rhapsido results
FierceBiotech 4. Feb. 2026 Novartis shakes up early pipeline with 6 culls and 2 new cancer candidates
Endpoints News 13. Jan. 2026 Novartis licenses radiopharma asset from Chinese biotech for $50M upfront
Endpoints News 12. Jan. 2026 Novartis, SciNeuro to work together on preclinical amyloid-targeting drug for Alzheimer’s